Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Research Communications in Chemical Pathology and Pharmacology|July 1, 1977
Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brainR W Fuller, H D SnoddyResearch Communications in Chemical Pathology and Pharmacology|October 1, 1984
Central serotonin antagonist activity of ketanserinR W Fuller, H D SnoddyJournal of Neural Transmission|January 1, 1979
Effect of mazindol on brain dopamine turnover in spiperone-treated ratsR W Fuller, H D SnoddyEndocrinology|October 1, 1979
The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in ratsR W Fuller, H D SnoddyEndocrine Research Communications|January 1, 1977
Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated ratsR W Fuller, H D SnoddyThe Journal of Pharmacy and Pharmacology|October 1, 1985
Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in ratsR W Fuller, H D SnoddyLife Sciences|December 5, 1983
Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brainR W Fuller, H D SnoddyResearch Communications in Chemical Pathology and Pharmacology|September 1, 1978
Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in ratsR W Fuller, H D SnoddyResearch Communications in Chemical Pathology and Pharmacology|July 1, 1992
Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidateR W Fuller, H D SnoddyThe Journal of Pharmacy and Pharmacology|October 1, 1986
Effect of fluoxetine pretreatment on the neurochemical changes induced by amfonelic acid combined with spiperone in ratsR W Fuller, H D SnoddyPageof 5